Publication | Closed Access

Sarcopenia, obesity, and inflammation—results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study

ObesityMetabolic SyndromeHypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular PharmacologyPharmacotherapySarcopenic ObesityPublic HealthPharmacologySarcopenia